RT Journal Article SR Electronic T1 Seroprevalence of SARS-CoV-2 infection in the Colombo Municipality region, Sri Lanka JF medRxiv FD Cold Spring Harbor Laboratory Press SP 2021.06.18.21259143 DO 10.1101/2021.06.18.21259143 A1 Chandima Jeewandara A1 Dinuka Guruge A1 Inoka Sepali Abyrathna A1 Saubhagya Danasekara A1 Banuri Gunasekera A1 Pradeep Darshana Pushpakumara A1 Deshan Madhusanka A1 Deshni Jayathilaka A1 Thushali Ranasinghe A1 Gayasha Somathilaka A1 Shyrar Tanussiya A1 Tibutius Tanesh Jayadas A1 Heshan Kuruppu A1 Nimasha Thashmi A1 Michael Harvie A1 Ruwan Wijayamuni A1 Lisa Schimanski A1 T.K. Tan A1 Pramila Rijal A1 Julie Xiao A1 Graham S. Ogg A1 Alain Townsend A1 Gathsaurie Neelika Malavige YR 2021 UL http://medrxiv.org/content/early/2021/06/23/2021.06.18.21259143.abstract AB Background As the Municipality Council area in Colombo (CMC) experienced the highest number of cases until end of January 2021, in Sri Lanka, we carried out a serosurvey prior to initiation of the vaccination program to understand the extent of the SARS-CoV-2 outbreak.Methods SARS-CoV-2 seropositivity was determined in 2547 individuals between the ages of 10 to 86 years, by the Wantai total antibody ELISA. We also compared to seroprevalence using the haemagglutination test (HAT) to evaluate its usefulness in carrying out serosurveys.Results The overall seropositivity rate was 24.46%, while seropositivity by HAT was 18.9%. Although the SARS-CoV-2 infection detection rates by PCR were highest in the population between the ages of 20 to 60 years of age, the seropositivity rates were equal among all age groups. The seropositivity rate was highest in the 10 to 20 age group (34.03%), whereas the PCR positivity rates was 9.8%. Differences in the PCR positivity rates and seropositivity rates were also seen in 60- to 70-year-olds (8.9% vs 30.4%) and in individuals >70 year (4.1% vs 1.2%). The seropositivity rates of the females was 29.7% (290/976), which was significantly higher (p<0.002) than in males 21.2% (333/1571).Conclusions A high seroprevalence rate (24.5%) was seen in all age groups in the CMC suggesting that a high level of transmission was seen during this area. The PCR positivity rates, appear to underestimate the true extent of the outbreak and the age groups which were infected.Competing Interest StatementThe authors have declared no competing interest.Funding StatementWe are grateful to the World Health Organization, UK Medical Research Council and the Foreign and Commonwealth Office for support. T.K.T. is funded by the Townsend-Jeantet Charitable Trust (charity number 1011770) and the EPA Cephalosporin Early Career Researcher Fund. A.T. are funded by the Chinese Academy of Medical Sciences (CAMS) Innovation Fund for Medical Science (CIFMS), China (grant no. 2018-I2M-2-002).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethics approval was obtained from the Ethics Review Committee of the University of Sri Jayewardenepura.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data is available within the manuscript file and the figures.